The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2024
Filed:
Dec. 19, 2022
Applicant:
The Procter & Gamble Company, Cincinnati, OH (US);
Inventors:
Brooke Michele Cochran, Cincinnati, OH (US);
Brian Xiaoqing Song, Mason, OH (US);
Howard David Hutton, III, Oregonia, OH (US);
Andrei Sergeevich Bureiko, Cincinnati, OH (US);
Peter Herbert Koenig, Montgomery, OH (US);
Assignee:
The Procter & Gamble Company, Cincinnati, OH (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/04 (2006.01); A61K 8/20 (2006.01); A61K 8/44 (2006.01); A61K 8/46 (2006.01); A61K 8/73 (2006.01); A61K 8/81 (2006.01); A61K 8/89 (2006.01); A61Q 5/00 (2006.01); A61Q 5/02 (2006.01); A61Q 5/12 (2006.01); A61Q 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 8/046 (2013.01); A61K 8/20 (2013.01); A61K 8/44 (2013.01); A61K 8/442 (2013.01); A61K 8/466 (2013.01); A61K 8/731 (2013.01); A61K 8/737 (2013.01); A61K 8/817 (2013.01); A61K 8/89 (2013.01); A61Q 5/006 (2013.01); A61Q 5/02 (2013.01); A61Q 5/12 (2013.01); A61Q 19/10 (2013.01); A61K 2800/262 (2013.01); A61K 2800/30 (2013.01); A61K 2800/5426 (2013.01); A61K 2800/596 (2013.01); A61K 2800/87 (2013.01);
Abstract
Personal cleansing compositions having an anionic surfactant, cationic deposition polymer, a level of inorganic salt of from about 0 to about 1 wt %, and an aqueous carrier. The composition is substantially free of sulfate containing surfactants. The composition can further comprise amphoteric surfactants. The composition remains phase stable, and minimizes coacervate formulation until after dilution with water.